Atlas Trials

Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure

Clinical trial NCT01802593 · TERMINATED

Trial details

NCT number
NCT01802593
Sponsor
Prof. Arie Levine
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2013-02-01
Primary completion
2015-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.